Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Endocrinology

• Publication date

  2013-02-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.2013-1915PMID 23397032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Endocrine and Paracrine Factors in the Adaptation of Bone to Mechanical Loading

  2011influential reference
• Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.

  2010influential reference
• Mechanical Stress Activates Smad Pathway through PKCδ to Enhance Interleukin-11 Gene Transcription in Osteoblasts

  2010influential reference
• Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice.

  2010influential reference
• Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.

  2010influential reference
• Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts.

  2009cited by this paper
• Mechanical stress induces Interleukin-11 expression to stimulate osteoblast differentiation.

  2009influential reference
• Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.

  2009influential reference
• Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

  2008influential reference
• Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia

  2008influential reference
• Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

  2007cited by this paper
• Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system.

  2006influential reference
• Mitogenic signalling and the p16INK4a–Rb pathway cooperate to enforce irreversible cellular senescence

  2006influential reference
• Mechanisms of glucocorticoid action in bone

  2005influential reference
• Interleukin‐11 Receptor Signaling Is Required for Normal Bone Remodeling

  2005influential reference
• Transcriptional Induction of FosB/ΔFosB Gene by Mechanical Stress in Osteoblasts*

  2004influential reference
• Interleukin-11 as a Stimulatory Factor for Bone Formation Prevents Bone Loss with Advancing Age in Mice*

  2002influential reference
• Mechanisms of Glucocorticoid Action in Bone

  2002cited by this paper
• PTH regulates fetal blood calcium and skeletal mineralization independently of PTHrP.

  2001influential reference
• Comparison of Trabecular Bone Microarchitecture and Remodeling in Glucocorticoid‐Induced and Postmenopausal Osteoporosis

  2001influential reference
• Bone Mass Continues to Increase at the Hip After Parathyroid Hormone Treatment Is Discontinued in Glucocorticoid‐Induced Osteoporosis: Results of a Randomized Controlled Clinical Trial

  2000influential reference
• Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1.

  1999influential reference
• Effects of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: possible mechanisms of glucocorticoid-induced bone loss.

  1999influential reference
• Reduced Expression of Interleukin‐11 in Bone Marrow Stromal Cells of Senescence‐Accelerated Mice (SAMP6): Relationship to Osteopenia with Enhanced Adipogenesis

  1998influential reference
• Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

  1998influential reference
• Parathyroid Hormone versus Phorbol Ester Stimulation of Activator Protein-1 Gene Family Members in Rat Osteosarcoma Cells

  1997influential reference
• Involvement of Different Second Messengers in Parathyroid Hormone– and Interleukin‐1–Induced Interleukin‐6 and Interleukin‐11 Production in Human Bone Marrow Stromal Cells

  1997influential reference
• In vivo demonstration that parathyroid hormone and parathyroid hormone–related protein stimulate expression by osteoblasts of interleukin‐6 and leukemia inhibitory factor

  1996influential reference
• Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow.

  1995influential reference
• Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion.

  1994influential reference
• Interleukin-11: a new cytokine critical for osteoclast development.

  1994influential reference
• Regulation of cytokine expression in osteoblasts by parathyroid hormone: Rapid stimulation of interleukin‐6 and leukemia inhibitory factor mRNA

  1993influential reference
• Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures.

  1993influential reference
• Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin‐11

  1991cited by this paper

• Therapeutic Management of Glucocorticoid-Induced Osteoporosis with a Focus on Older Adults: A Narrative Review

  2025cites this paper
• Relationship between bone turnover markers and renal disease in elderly patients with type 2 diabetes: a cross-sectional study

  2024cites this paper
• Bone–fat linkage via interleukin-11 in response to mechanical loading

  2024cites this paper
• Roles of IL-11 in the regulation of bone metabolism

  2024cites this paper
• The Emerging Role of Interleukin-(IL)-11/IL-11R in Bone Metabolism and Homeostasis: From Cytokine to Osteokine

  2023cites this paper
• Zoledronic acid and teriparatide have a complementary therapeutic effect on aseptic loosening in a rabbit model

  2021cites this paper
• Osteoblast/osteocyte-derived interleukin-11 regulates osteogenesis and systemic adipogenesis

  2021cites this paper
• Pharmacological study of teriparatide on ovariectomy-induced hyperalgesia in rats [an abstract of entire text]

  2020cites this paper
• Teriparatide relieves ovariectomy-induced hyperalgesia in rats, suggesting the involvement of functional regulation in primary sensory neurons by PTH-mediated signaling

  2020cites this paper
• The Role of ΔFosB on the Pro-survival Effect of PTHrP in Goat Mammary Epithelial Cells

  2016cites this paper
• Genome-Wide Chromatin Landscape Transitions Identify Novel Pathways in Early Commitment to Osteoblast Differentiation

  2016cites this paper
• Glucocorticoid-Induced Osteoporosis.

  2015cites this paper
• Molecular Actions of Parathyroid Hormone

  2015cites this paper
• PTH-Induced Osteoblast Proliferation Requires Upregulation of the Ubiquitin-Specific Peptidase 2 (Usp2) Expression

  2015cites this paper
• Molecular determinants of glucocorticoid actions in inflammatory joint diseases.

  2013cites this paper